Filtered By:
Specialty: Cardiology
Management: WHO

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 37 results found since Jan 2013.

Cost-Effectiveness of Clopidogrel-Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke Stroke
Conclusions Early 90-day clopidogrel-aspirin regimen for acute TIA or minor stroke is highly cost-effective in China. Although clopidogrel is generic, Plavix is brand in China. If Plavix were generic, treatment with clopidogrel-aspirin would have been cost saving.
Source: JAHA:Journal of the American Heart Association - June 5, 2014 Category: Cardiology Authors: Pan, Y., Wang, A., Liu, G., Zhao, X., Meng, X., Zhao, K., Liu, L., Wang, C., Johnston, S. C., Wang, Y., Wang, Y., the CHANCE Investigators Tags: Stroke Source Type: research

PS025 La Carta De Santiago: Priorities for Stroke Prevention and Treatment in the Americas
According to the World Health Organization (WHO), stroke claims 5.5 million lives globally each year. As the No. 2 killer worldwide, it is estimated that 17.3 million people die from cardiovascular disease including stroke each year, representing 30% of all global deaths. That equates to six people dying from stroke every 60 seconds and unfortunately the burden of stroke is disproportionately affecting low to middle income countries exceeding those of high income countries by 20%.[1] In some Latin American countries, ischemic heart disease and stroke are ranked as the No.
Source: CVD Prevention and Control - May 27, 2016 Category: Cardiology Authors: S. Cruz Flores, D. Vaca McGhie, Latin American Leadership Steering Group for Latin American Summit Tags: Poster Abstract Source Type: research

The “know your numbers” program in Atahualpa — A pilot study aimed to reduce cardiovascular diseases and stroke burden in rural communities of developing countries
The burden of cardiovascular diseases and stroke is steadily increasing in many low- and middle-income countries, to the point that these conditions have been considered as the new epidemics of the developing world . The World Health Organization has set a global goal of reducing deaths from non-communicable diseases (including stroke and ischemic heart disease) by 25% by 2025 . It seems that people living in rural communities are most vulnerable to these “new epidemics”. There, a process of epidemiologic transition is aggravated by poor access to medical care and by income issues that preclude people to afford the cos...
Source: International Journal of Cardiology - May 6, 2013 Category: Cardiology Authors: Oscar H. Del Brutto, Martha Montalván, Daniel Tettamanti, Ernesto Peñaherrera, Rocío Santibáñez, Freddy Pow-Chon-Long, Victor J. Del Brutto Tags: Letters to the Editor Source Type: research

COVID-19 induced ischemic stroke and mechanisms of viral entry in brain and clot formation: a systematic review and current update
Conclusion: Data available in the literature is not adequate to come to a conclusion. Therefore, there is a need to carry out further studies to delineate the possible association between SCV-2 induced IS.PMID:35412938 | DOI:10.1080/00207454.2022.2056460
Source: Atherosclerosis - April 12, 2022 Category: Cardiology Authors: Abhilash Ludhiadch Swaraj Ranjan Paul Rahul Khan Anjana Munshi Source Type: research

Adherence to Medical Therapy and the Global Burden of Cardiovascular Disease ∗
Ischemic heart disease and cerebrovascular disease account for>20% of worldwide mortality and are the 2 leading causes of death on a global basis (1). Although mortality from ischemic heart disease is greater than that from stroke worldwide, the mortality from stroke is actually higher than from ischemic heart disease in 39% of countries. For example, mortality from stroke is generally higher than that for ischemic heart disease in China, Africa, and South America. In addition, stroke disability–adjusted life-year loss rates exceed ischemic heart disease-related disability in 32% of countries (2). Because of this, strate...
Source: Journal of the American College of Cardiology - March 29, 2016 Category: Cardiology Source Type: research

Global Trend in Overweight and Obesity and Its Association With Cardiovascular Disease Incidence.
Abstract Although the global prevalence of both the overweight and obese is on the rise, there are variations among regions or countries, and sexes. Approximately half or more than half of the population are overweight/obese defined as body mass index ≥25 kg/m(2)in the Americas (61.1%), Europe (54.8%), and Eastern Mediterranean (46.0%) according to the World Health Organization, while a much lower prevalence is observed in Africa (26.9%), South-East Asia (13.7%), and the Western Pacific (25.4%). Females are more likely to be overweight/obese in the Eastern Mediterranean, Africa, South-East Asia and the majority ...
Source: Circulation Journal - November 11, 2014 Category: Cardiology Authors: Yatsuya H, Li Y, Hilawe EH, Ota A, Wang C, Chiang C, Zhang Y, Uemura M, Osako A, Ozaki Y, Aoyama A Tags: Circ J Source Type: research

To Screen or Not to Screen? Examining the Arguments Against Screening for Atrial Fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with a lifetime risk of one in four of developing AF over the age of 40 years. Around 40% of patients are asymptomatic, which is of concern as AF is a major risk factor for stroke. Early detection and appropriate management reduces stroke risk by two-thirds. Atrial fibrillation screening is now recommended in international guidelines, but there are some common arguments against screening. Overall, to be of value any screening program must fulfil the World Health Organization (WHO) Wilson and Jungner criteria for screening programs.
Source: Heart, Lung and Circulation - May 24, 2017 Category: Cardiology Authors: Lis Neubeck, Jessica Orchard, Nicole Lowres, S. Ben Freedman Tags: Review Source Type: research

2017 Guidelines for the management of arterial hypertension in primary health care in Portuguese-speaking countries
Publication date: Available online 29 November 2017 Source:Revista Portuguesa de Cardiologia (English Edition) Author(s): Gláucia Maria Moraes de Oliveira, Miguel Mendes, Marcus Vinícius Bolívar Malachias, João Morais, Osni Moreira Filho, Armando Serra Coelho, Daniel Pires Capingana, Vanda Azevedo, Irenita Soares, Alda Menete, Beatriz Ferreira, Miryan Bandeira dos Prazeres Cassandra Soares, Mário Fernandes The World Health Organization goal's to reduce mortality due to chronic non-communicable diseases by 2% per year demands a huge effort from member countries. This challenge for health professionals requires global ...
Source: Revista Portuguesa de Cardiologia - November 29, 2017 Category: Cardiology Source Type: research

Plasminogen Activator Inhibitor-1: A Novel Therapeutic Target for Hypertension?
Abstract Hypertension is the most common reversible risk factor for stroke, myocardial infarction, and heart failure, affecting greater than 60 million individuals in the United State alone and 1 billion globally(1). According to the World Health Organization, hypertension is now the leading cause of preventable death worldwide(2). Importantly, the prevalence and complications of hypertension increase significantly with age. However, despite the availability of many anti-hypertensive agents of distinct pharmacologic classes and evidence-based guideline recommendations for step-wise, multi-drug regimens, control of...
Source: Circulation - October 3, 2013 Category: Cardiology Authors: Simon DI, Simon NM Tags: Circulation Source Type: research

Sexual counselling for individuals with cardiovascular disease and their partners: A Consensus Document From the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP)
After a cardiovascular event, patients and their families often cope with numerous changes in their lives, including dealing with consequences of the disease or its treatment on their daily lives and functioning. Coping poorly with both physical and psychological challenges may lead to impaired quality of life. Sexuality is one aspect of quality of life that is important for many patients and partners that may be adversely affected by a cardiac event. The World Health Organization defines sexual health as ‘... a state of physical, emotional, mental and social well-being in relation to sexuality; it is not merely the ...
Source: European Heart Journal - November 1, 2013 Category: Cardiology Authors: Steinke, E. E., Jaarsma, T., Barnason, S. A., Byrne, M., Doherty, S., Dougherty, C. M., Fridlund, B., Kautz, D. D., Martensson, J., Mosack, V., Moser, D. K., on behalf of the Council on Cardiovascular and Stroke Nursing of the American Heart Association a Tags: ESC POSITION PAPER Source Type: research

President's Page: Heart Month and the American College of Cardiology: A Lesson in Partnerships, Member Values, and Patient Education
The global statistics surrounding cardiovascular disease speak for themselves. Not only is cardiovascular disease the number 1 cause of death globally, but this trend is also expected to continue well into the future. According to the World Health Organization, the number of deaths from cardiovascular diseases, mainly from heart disease and stroke, is expected to reach 23.3 million by 2030 .
Source: Journal of the American College of Cardiology - February 3, 2014 Category: Cardiology Authors: John Gordon Harold Tags: FROM THE ACC Source Type: research

The Global Burden of Cardiovascular Diseases, 1990–2010
Cardiovascular diseases (CVD), principally ischemic heart disease and stroke, remain the leading cause of mortality worldwide and a major contributor to disability and rising healthcare costs . In 2010 alone, CVD was a primary cause of 15.6 million global deaths and an estimated US$863 billion in direct healthcare costs and productivity losses worldwide . In fact, these costs are projected to reach US$20 trillion by the year 2030 . In spite of this huge toll on global health and development, reports from the Institute of Medicine, the World Heart Federation, and the World Health Organization state that CVD is rarely on the...
Source: CVD Prevention and Control - March 1, 2014 Category: Cardiology Authors: George A. Mensah, Andrew E. Moran, Gregory A. Roth, Jagat Narula Tags: Editor's Page Source Type: research

Progress on Salt Reduction in the Pacific Islands: From Strategies to Action
The objective of this analysis was to review progress to date and identify regional actions needed to support PICs and ensure they achieve the global target to reduce population salt intake by 30% by 2025.
Source: Heart, Lung and Circulation - December 9, 2014 Category: Cardiology Authors: Anthea Christoforou, Wendy Snowdon, Nevalyn Laesango, Seta Vatucawaqa, Daniel Lamar, Lawrence Alam, Kippier Lippwe, Iemaima Lise Havea, Karen Tairea, Peter Hoejskov, Temo Waqanivalu, Jacqui Webster Source Type: research

Management of NCD in Low- and Middle-Income Countries
Publication date: December 2014 Source:Global Heart, Volume 9, Issue 4 Author(s): William Checkley , Hassen Ghannem , Vilma Irazola , Sylvester Kimaiyo , Naomi S. Levitt , J. Jaime Miranda , Louis Niessen , Dorairaj Prabhakaran , Cristina Rabadán-Diehl , Manuel Ramirez-Zea , Adolfo Rubinstein , Alben Sigamani , Richard Smith , Nikhil Tandon , Yangfeng Wu , Denis Xavier , Lijing L. Yan Noncommunicable disease (NCD), comprising cardiovascular disease, stroke, diabetes, and chronic obstructive pulmonary disease, are increasing in incidence rapidly in low- and middle-income countries (LMICs). Some patients have access to th...
Source: Global Heart - January 15, 2015 Category: Cardiology Source Type: research